68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol

被引:80
作者
Ruf, Juri [1 ,2 ]
Schiefer, Jan [1 ]
Furth, Christian [1 ]
Kosiek, Ortud [1 ]
Kropf, Siegfried [3 ]
Heuck, Friederike [4 ]
Denecke, Timm [2 ]
Pavel, Marianne [4 ]
Pascher, Andreas [5 ]
Wiedenmann, Bertram [4 ]
Amthauer, Holger [1 ,2 ]
机构
[1] Univ Klinikum Magdeburg AoR, Klin Radiol & Nukl Med, D-39120 Magdeburg, Germany
[2] Charite, Campus Virchow Klinikum, Klin Strahlenheilkunde, D-13353 Berlin, Germany
[3] Otto Von Guericke Univ, Fak Med, Inst Biometrie & Med Informat, Magdeburg, Germany
[4] Charite, Campus Virchow Klinikum, Med Klin MS Hepatol & Gastroenterol, D-13353 Berlin, Germany
[5] Charite, Campus Virchow Klinikum, Klin Allgemein Viszeral & Transplantat Chirurg, D-13353 Berlin, Germany
关键词
neuroendocrine tumor; NET; Ga-68-DOTATOC; PET/CT; multiphase CT protocol; CARCINOID-TUMORS; CONTRAST-MEDIUM; HELICAL CT; MANAGEMENT; INTERFERON; METASTASES; IMPACT; GA-68; LIVER;
D O I
10.2967/jnumed.110.083741
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The diagnostic value of neuroendocrine tumor (NET) imaging using PET with integrated CT is dependent on both components. This retrospective study assessed the value of the single CT phases of a triple-phase (early arterial, portal-venous inflow, and venous) CT protocol in comparison to Ga-68-DOTATOC PET in a masked reading. Methods: Ga-68-DOTATOC PET/CT examinations from 51 patients with known or suspected NET were included. Two readers assessed the data of PET and each of the 3 CT phases for NET lesions independently (using a 3-point score: 1 = benign, 2 = indeterminate, and 3 = malignant) and by consensus (using binary benign/malignant interpretation only). Only lesions within the field of the abdominal scan were evaluated. Clinical and imaging follow-up, histopathology (if available), and the decision of an interdisciplinary truth-panel served as a standard of reference. In addition to the calculation of standard statistical parameters (including general linear mixed models), interobserver reliability was estimated (Cohen's kappa). Results: Of 510 abdominal lesions observed, 354 were classified as malignant. Sensitivity was 77.1% for combined triple-phase CT, 53.4% for arterial CT, 66.1% for portal-venous CT, 66.9% for venous CT, and 72.8% for PET. The respective specificities were 85.3%, 92.9%, 92.3%, 89.7%, and 97.4%, and the respective accuracies were 79.6%, 65.5%, 74.1%, 73.9%, and 80.4%. Although arterial CT was found to be inferior to PET, portal-venous CT, and venous CT (P < 0.001), the differences between the other scans were not significant. Detection was exclusively by PET for 16.1% of lesions, by triple-phase CT for 20.3%, by arterial CT for 0.5%, by portal-venous CT for 3.9%, and by venous CT for 3.9%. Regarding interobserver reliability, the kappa-value was 0.768 for PET, 0.391 for triple-phase CT, 0.577 for arterial CT, 0.583 for portal-venous CT, and 0.482 for venous CT. Conclusion: No CT phase can be omitted in NET imaging, and the triple-phase protocol continues to be strongly recommended also for PET/CT.
引用
收藏
页码:697 / 704
页数:8
相关论文
共 50 条
  • [31] Head-to-Head Comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: A Prospective Study of 59 Patients with Neuroendocrine Tumors
    Johnbeck, Camilla B.
    Knigge, Ulrich
    Loft, Annika
    Berthelsen, Anne K.
    Mortensen, Jann
    Oturai, Peter
    Langer, Seppo W.
    Elema, Dennis R.
    Kjaer, Andreas
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 451 - 457
  • [32] Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours
    Schreiter, Nils F.
    Brenner, Winfried
    Nogami, Munenobu
    Buchert, Ralph
    Huppertz, Alexander
    Pape, Ulrich-Frank
    Prasad, Vikas
    Hamm, Bernd
    Maurer, Martin H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (01) : 72 - 82
  • [33] 68Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
    Boughdad, Sarah
    Latifyan, Sofiya
    Fenwick, Craig
    Bouchaab, Hasna
    Suffiotti, Madeleine
    Moslehi, Javid J.
    Salem, Joe-Elie
    Schaefer, Niklaus
    Nicod-Lalonde, Marie
    Costes, Julien
    Perreau, Matthieu
    Michielin, Olivier
    Peters, Solange
    Prior, John O.
    Obeid, Michel
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (10)
  • [34] Qualitative and quantitative image analysis of CT and MR imaging in patients with neuroendocrine liver metastases in comparison to 68Ga-DOTATOC PET
    Flechsig, Paul
    Zechmann, Christian M.
    Schreiweis, Julian
    Kratochwil, Clemens
    Rath, Daniel
    Schwartz, Lawrence H.
    Schlemmer, Heinz-Peter
    Kauczor, Hans-Ulrich
    Haberkorn, Uwe
    Giesel, Frederik L.
    EUROPEAN JOURNAL OF RADIOLOGY, 2015, 84 (08) : 1593 - 1600
  • [35] Role of 68Ga-DOTATOC PET/CT in initial evaluation of patients with suspected bronchopulmonary carcinoid
    Venkitaraman, Balasubramanian
    Karunanithi, Sellam
    Kumar, Arvind
    Khilnani, G. C.
    Kumar, Rakesh
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (05) : 856 - 864
  • [36] False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT
    Haidar, Mohamad B.
    Abou Zeid, Farah A.
    Meguerian, Zarouhie Z.
    Al-Ibraheem, Akram N.
    Noun, Peter E.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 690 - 692
  • [37] 68Ga-DOTATOC-PET/MRI and 11C-5-HTP-PET/MRI are superior to 68Ga-DOTATOC-PET/CT for neuroendocrine tumour imaging
    Jawlakh, Hiba
    Velikyan, Irina
    Welin, Staffan
    Sundin, Anders
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 (06)
  • [38] Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?
    Marius E. Mayerhoefer
    Matthias Schuetz
    Silvia Magnaldi
    Michael Weber
    Siegfried Trattnig
    Georgios Karanikas
    European Radiology, 2012, 22 : 938 - 946
  • [39] Detection of cranial meningiomas: comparison of 68Ga-DOTATOC PET/CT and contrast-enhanced MRI
    Ali Afshar-Oromieh
    Frederik L. Giesel
    Heinz G. Linhart
    Uwe Haberkorn
    Sabine Haufe
    Stephanie E. Combs
    Dino Podlesek
    Michael Eisenhut
    Clemens Kratochwil
    European Journal of Nuclear Medicine and Molecular Imaging, 2012, 39 : 1409 - 1415
  • [40] Comparative Biodistribution and Radiation Dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in Patients with Neuroendocrine Tumors
    Sandstrom, Mattias
    Velikyan, Irina
    Garske-Roman, Ulrike
    Sorensen, Jens
    Eriksson, Barbro
    Granberg, Dan
    Lundqvist, Hans
    Sundin, Anders
    Lubberink, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (10) : 1755 - 1759